Statistics
TarBase v.8
Help
Related Pathways
Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-183-3p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 377, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput 		Publications Cell lines Tissues Pred. Score
GPR137B hsa-miR-183-3p low: 0 high: 12 1 1 1 -
High-throughput experiments (12 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:236208504-236208522 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCNI hsa-miR-183-3p low: 0 high: 3 3 3 3 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr4:77047902-77047919 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:77047902-77047919 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr4:77058601-77058623 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF91 hsa-miR-183-3p low: 0 high: 3 3 3 3 0.963
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr19:23357804-23357827 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:23361191-23361217 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:23361275-23361301 PAR-CLIP POSITIVE DIRECT TarBase 7.0
COL4A5 hsa-miR-183-3p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chrX:108695444-108695464 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chrX:108695444-108695464 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:108695444-108695464 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUCKS1 hsa-miR-183-3p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:205727710-205727731 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:205716958-205716979 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:205716958-205716979 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SHOC2 hsa-miR-183-3p low: 0 high: 3 1 1 1 0.499
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr10:111012297-111012315 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr10:111012297-111012315 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr10:111012297-111012315 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF850 hsa-miR-183-3p low: 0 high: 3 2 2 2 0.607
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:36750047-36750063 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:36748635-36748654 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr19:36748551-36748573 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HMGB2 hsa-miR-183-3p low: 0 high: 2 3 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:173332005-173332030 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr4:173332005-173332030 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Hafner M. et al. 2010 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
Whisnant Adam W et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
PABPC1 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr8:100715533-100715557 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:100715533-100715557 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DNAJA1 hsa-miR-183-3p low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:33030519-33030545 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr9:33030519-33030545 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DICER1 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr14:95086535-95086555 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr14:95086535-95086555 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SSR3 hsa-miR-183-3p low: 0 high: 2 2 2 2 0.862
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:156543064-156543083 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:156543064-156543083 HITS-CLIP POSITIVE DIRECT TarBase 7.0
YWHAQ hsa-miR-183-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:9584625-9584641 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:9584625-9584641 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DRAM1 hsa-miR-183-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:101922070-101922089 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:101921600-101921627 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MINK1 hsa-miR-183-3p low: 0 high: 2 1 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:4898021-4898047 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:4898021-4898047 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PURB hsa-miR-183-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr7:44880152-44880171 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:44879649-44879677 PAR-CLIP POSITIVE DIRECT TarBase 7.0
NPTN hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr15:73560047-73560071 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr15:73560047-73560071 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PRKAA2 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:56711693-56711718 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:56711693-56711718 HITS-CLIP POSITIVE DIRECT TarBase 7.0
OXR1 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:106270222-106270250 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr8:106270222-106270250 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CTNNB1 hsa-miR-183-3p low: 0 high: 2 1 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:41240095-41240117 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:41240413-41240441 HITS-CLIP POSITIVE DIRECT TarBase 7.0
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more
I accept